
|Articles|February 1, 2005
DC-based vaccines gaining ground
Tampa, Fla. — Although development of melanoma vaccines based on dendritic cells (DCs) lags behind that of more established approaches, it's rapidly moving from the lab bench into clinical trials.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Hilary Baldwin, MD, Highlights Emerging Acne and Rosacea Therapies at Elevate-Derm
2
Education and Engagement Drive Momentum in Hair Disorders
3
Douglas DiRuggiero, PA-C, DMSc, Recognized at the Elevate-Derm Fall Conference
4
Targeting Metabolism to Control Effector and Regulatory T Cells
5



















